Life sciences

7 stories

If you haven’t been following the breakup of the 35-year-old venture capital firm Atlas Venture, which once invested in both tech and biotech, partner Peter Barrett sums it up this way: “In this divorce, the life sciences side kept the name, and the tech side got the house.” So Atlas’s team of tech investors is casting about for a new name, but staying in East Cambridge. And the biotech crew, still known as Atlas, just moved into new offices yesterday atop 400 Technology Square in Cambridge, midway between the Kendall and Central stations on the Red Line.More →

The big players of the biopharma world descend on San Francisco next week for the annual JP Morgan Healthcare Conference, and in advance of it, Boston-based PureTech is announcing it has raised $50 million in new funding. PureTech takes successful research out of academic labs, and assembles teams that can move it toward commercialization. Among its projects are startup companies focused on obesity, hair growth, drug delivery without needles, and therapeutic video games.More →